Developing an adaptive paediatric intensive care unit platform trial with key stakeholders: a qualitative study

Tracy Karen Mitchell1, Julie C Menzies2, Padmanabhan Ramnarayan3

  • 1Public Health, Policy and Systems, University of Liverpool, Liverpool, UK Tracy.Mitchell@Liverpool.ac.uk.

BMJ Open
|January 8, 2025
PubMed

Insights

This study found that young people, parents, and pediatric intensive care unit (PICU) staff found the proposed adaptive platform trial acceptable. Their input will help design a family-centered trial to improve critically ill children's treatment.

Area of Science:

  • Pediatric Intensive Care
  • Clinical Trial Design
  • Qualitative Research

Background:

  • Platform trials accelerate treatment discovery in adults, as seen during COVID-19.
  • Adaptive platform trials offer efficient testing of multiple interventions.
  • Paediatric intensive care (PICU) needs innovative trial designs.

Purpose of the Study:

  • To inform the design of the UK's first adaptive platform trial in PICU.
  • To incorporate perspectives of young patients, parents/carers, and PICU staff.
  • To ensure a family-centered and operationalizable trial protocol.

Main Methods:

  • Qualitative study using semistructured focus groups.
  • Reflexive thematic analysis of collected data.
  • Involved 86 participants: 18 young people, 15 parents/carers, 53 PICU staff.

Main Results:

  • Stakeholders found the proposed PICU platform trial acceptable.
  • Key design insights include broad eligibility, prioritizing child quality of life and survival outcomes.
  • Recommendations provided for governance and overcoming trial challenges.

Conclusions:

  • The proposed adaptive PICU platform trial is acceptable to key stakeholders.
  • Stakeholder input ensures a rigorous yet family-centered design.
  • Findings inform a protocol to generate high-quality evidence for critically ill children.
Abstract